slow, plodding scientific research and the demands of Wall Street are on stark display in the world of Alzheimer's drug...
Given that 26 million people worldwide have Alzheimer's disease and 106 million could be afflicted by 2050, any treatment that alters the course of the disease will become a multi-billion-dollar drug. Major pharmaceutical companies and biotech startups are racing to develop the first drugs to delay or reverse Alzheimer’s. Medical device makers are also developing screening tests to more accurately diagnose Alzheimer’s, and health care providers are trying to find ways to better manage patients.
Alzheimer's is part of Business Exchange, suggested by Cathy Arnst. This topic contains 1,254 news and 1,153 blog items. Read updated news, blogs, and resources about Alzheimer's. Find user-submitted articles and reactions on Alzheimer's from like-minded professionals.
Please add new articles to this topic
analyst John Boris says he's downgrading Wyeth (WYE) shares to sell from hold as he removes the experimental...
percent to $81.2 million, chiefly reflecting Elan's efforts to produce treatments and a potential cure for the...
Extract not available.
Top Sources: Alzheimer's
- US News
- New York Times
- Mail Online UK
- Los Angeles Times
- Boston Globe
Please wait, content being added to topic...